Article citationsMore>>

Greenspan, S.L., Perera, S., Ferchak, M.A., Nace, D.A. and Resnick, N.M. (2015) Efficacy and Safety of Single-Dose Zoledronic Acid for Osteoporosis in Frail Elderly Women a Randomized Clinical Trial. Journal of the American Medical Association, 175, 913-921.

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.